Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control?

The Journal of Hospital Infection
Bernhard Meyer, B Cookson

Abstract

Increased numbers of healthcare-acquired infections, including those caused by antibiotic-resistant microbes, have created a need for improved infection control use of disinfection regimens. Commensurate with this has been an increasing number of reports on resistance to a wide variety of antimicrobials, including biocides. Cross-resistance between these biocides and other biocidal or antimicrobial agents has been well-documented. Much of the literature lacks clear distinctions between adaptation of organisms to exposure to biocides, which reverses upon removal of the biocide, as opposed to resistance. Depending on the genetic basis of this resistance, it may be high level and not readily reversible. This lack of clear definitions complicates the evaluation of the relevance of these phenomena in practice. In this review we propose definitions of adaptative processes and biocide resistance and survey the literature according to these definitions. We conclude that the current risks to healthcare delivery caused by resistance related to biocides are low, provided that biocides are used under appropriate conditions. The need for further research is addressed.

References

Mar 1, 1997·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·R L AndersonM S Favero
Jul 2, 1999·The Journal of Hospital Infection·S DharanD Pittet
Mar 14, 2000·The Journal of Pharmacy and Pharmacology·A D Russell
Jul 7, 2000·The Journal of Antimicrobial Chemotherapy·M T Suller, A D Russell
Oct 31, 2000·Applied and Environmental Microbiology·L MereghettiA Audurier
May 19, 2001·The Journal of Hospital Infection·S M MurtoughA D Russell
May 23, 2001·Archives of Biochemistry and Biophysics·J VillalaínV Micol
Jul 10, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C S HigginsT R Walsh
Feb 2, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M S SidhuA Holck
Jul 2, 2002·The Journal of Hospital Infection·S KõljalgM Mikelsaar
Feb 21, 2003·International Journal of Food Microbiology·Janne LundénHannu Korkeala
Apr 15, 2003·Clinical Microbiology Reviews·Peter Gilbert, Andrew J McBain
Jun 17, 2003·Journal of Applied Microbiology·S LangsrudG Sundheim
Jul 23, 2004·The Journal of Antimicrobial Chemotherapy·L P RandallM J Woodward
Sep 16, 2005·Journal of Applied Microbiology·P Gilbert, L E Moore
Jun 14, 2006·International Journal of Food Microbiology·Bernhard Meyer
Oct 25, 2006·Antimicrobial Agents and Chemotherapy·Christopher J IoannouStephen P Denyer
May 15, 2007·The Journal of Hospital Infection·H WisplinghoffH Seifert
Oct 3, 2007·Antimicrobial Agents and Chemotherapy·David J WeberEmily E Sickbert-Bennett
Jun 3, 2008·Applied and Environmental Microbiology·Louise E MooreAndrew J McBain
Jul 8, 2008·The Journal of Hospital Infection·D J H MartinJ-Y Maillard
Dec 26, 2008·The Journal of Hospital Infection·L K BergenL P Andersen
Feb 10, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mandy WoottonRobin A Howe
Feb 28, 2009·The Journal of Hospital Infection·A CottellJ-Y Maillard
Jun 10, 2009·BMC Medicine·Stephanie J DancerChris Robertson
Nov 10, 2009·Applied and Environmental Microbiology·Vicky G KastbjergHanne Ingmer
Dec 17, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·William R Jarvis

❮ Previous
Next ❯

Citations

Dec 27, 2012·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·E D OlthofG J A Wanten
Oct 21, 2011·Biofouling·A BridierF Dubois-Brissonnet
Jul 27, 2012·The Journal of Antimicrobial Chemotherapy·Carolyne HornerMark Wilcox
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Joe LatimerAndrew J McBain
Nov 1, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Dariusz BialoszewskiStefan Tyski
Oct 22, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mary LenahanCatherine M Burgess
Jan 21, 2016·Journal of Materials Science. Materials in Medicine·Joanna JońcaJulian Chojnowski
Nov 13, 2012·International Journal of Food Microbiology·Vicky G Kastbjerg, Lone Gram
Dec 27, 2011·The Journal of Hospital Infection·F Mustafa Awadel-KariemH O'Connor
Jun 15, 2011·The Journal of Hospital Infection·G McDonnell, P Burke
Jul 23, 2011·Veterinary Dermatology·Rebecca YoungTim Nuttall
Dec 21, 2010·Letters in Applied Microbiology·S SalehP J Collier
Mar 1, 2012·Journal of Medical Microbiology·Ana Mavri, Sonja Smole Možina
Dec 1, 2012·The Journal of Hospital Infection·J A OtterG L French
Nov 2, 2014·Applied and Environmental Microbiology·Charles P Gerba
Nov 3, 2016·Veterinary Surgery : VS·Denis VerwilghenAimie J Doyle
Nov 5, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B ChenS Liang
May 12, 2018·Critical Reviews in Microbiology·Fabian CieplikTim Maisch
Aug 27, 2018·Journal of Cellular Biochemistry·Deepika BiswasVishvanath Tiwari
Sep 14, 2014·Applied and Environmental Microbiology·Benjamin Zeitler, Ingrid Rapp
Apr 10, 2013·The Open Microbiology Journal·Sofia Santos CostaIsabel Couto
May 10, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alexsander Rodrigues Carvalho JuniorLuís Cláudio Nascimento da Silva
Sep 2, 2017·Antimicrobial Resistance and Infection Control·Seyda IgnakBulent Gurler
May 26, 2020·BMC Complementary Medicine and Therapies·Vanessa EichelUwe Frank

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Allison E AielloStuart B Levy
© 2021 Meta ULC. All rights reserved